Nachrichten zur West Pharmaceutical Services Inc. Aktie

3 Dividend Aristocrats to Buy Now Amid the Middle East Crisis

Middle East tensions rattle markets as oil tops $100. Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services stand out as dividend…

Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript

…

WSTs Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up

West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on…

West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of +11.21% and +1.35%, respectively, for the quarter ended December 2025. Do…

WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins?

West Pharmaceutical heads into Q4 with HVP demand likely lifting margins, but tariff risk looms as revenue and EPS targets…

West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

West Pharmaceutical (WST) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

WST Launches Synchrony S1 Prefillable Syringe at Pharmapack

West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.…

West Pharmaceutical Services Aktie: Wachstum des Marktes für Abnehmspritzen und andere Faktoren beflügeln das Geschäft

Paris (www.aktiencheck.de) - West Pharmaceutical Services-Aktienanalyse von BNP Paribas:Egmond Haidt von BNP Paribas nimmt die Aktie von West Pharmaceutical Services…

West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of +17.37% and +2.43%, respectively, for the quarter ended September 2025. Do…

West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2025 Transcript

…

West Pharmaceuticals - Pharmazulieferer profitiert von Nachzieheffekten aus der Pharma- und Biotechbranche!

Geschäftstreiber: Bei West Pharmaceuticals handelt sich um einen Produzenten von Komponenten und Geräten für die Herstellung von Pharmazeutika, Biologika, Impfstoffen…

West Pharmaceutical (WST) Upgraded to Strong Buy: Heres Why

West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings…

West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem

…

KeyBanc maintains Overweight rating on West Pharmaceutical stock By Investing.com

KeyBanc maintains Overweight rating on West Pharmaceutical stock…

WST Q2 Earnings Preview: Will the Stocks Segmental Edge Hold Up?

West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.…

Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES, June 30, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming…

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Heres is How to Trade

The mean of analysts price targets for West Pharmaceutical (WST) points to a 26.9% upside in the stock. While this…

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of…

The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 – WST

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

[Latest] Global Pharmaceutical Contract Packaging Market Size/Share Worth USD 34.80 Billion by 2034 at a 7.34% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

West Pharmaceutical (WST) Upgraded to Buy: Heres What You Should Know

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

dpa-AFX ProFeed